Chargement en cours...
HER2 status and disparities in luminal breast cancers
National Comprehensive Care Network guidelines for adjuvant treatment of invasive breast cancer are based on HER2 and hormone receptor (HR) status, where HR+ disease encompasses all estrogen receptor (ER)+ and/or progesterone receptor (PR)+ tumors. We sought to explore clinical and demographic diffe...
Enregistré dans:
| Publié dans: | Cancer Med |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4893351/ https://ncbi.nlm.nih.gov/pubmed/27250116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.757 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|